Antitumor vaccines

Details Antitumor vaccines Antitumor vaccines

1995-06-06

1998-04-14

Kishore, Gollamudi S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

436829, A61K 9127

Patent

active

057388679

ABSTRACT:
Antitumor vaccine compositions and methods for treating tumors that express the GA733-2 antigen are disclosed. The vaccines comprise a GS733-2 antigen in a liposomal carrier.

REFERENCES:
patent: 4343895 (1982-08-01), Sugaar
patent: 4557931 (1985-12-01), Irie et al.
patent: 5026557 (1991-06-01), Estis et al.
patent: 5141742 (1992-08-01), Brown et al.
Philips et al., Cancer det. & Prev. 14, #4, p. 1990, 1990.
Heath et al., Methods in Enzymology 1987 149, p.111.
Sela et al., Hybridoma 8, #4, 1989, p. 481.
Szala et al., PNAs 87, p. 3542, 1990.
DATABASE WPI-Week 9035 -Derwent Publications Ltd. London GB AN 90-266194 & JP 02 188 532 A (Otsuka Pharm Co Ltd) 24 Jul. 2990 -Abstract.
J. Gen Virol. vol 65, 1984, London (GB), pp. 1009-1014, XP002036804 A.R. Neurath et al. "Antibodies to hepatitis B surface antigen (HBsAg) elicited by immunization with a synthetic peptide covalently linked to liposomes"-whole document.
Sela et al., "Colon Carcinoma-Associated Glycoproteins Recognized by Monoclonal Antibodies Co-029 and GA22-2", Hybridoma 8(4):481-491 (1989).
Szala et al., "Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2", Proc. Natl. Acad. Sci. USA 87:3542-3546 (1990).

Affiliated with

Also associated with

Rating

Antitumor vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-632753